ClinicalTrials.govpublic full text
Observational, Non-interventional, Non Comparative Real Life Data Collection of Depo-Eligard® 7.5 mg, 22.5 mg and 45 mg in Male Prostate Cancer Patients
prostate cancer, phase 4, data collection, observational, depo-eligard, prospective, non-interventional, treatment
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 832760
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.